Aditxt, Inc. (NASDAQ:ADTX) Sees Significant Growth in Short Interest

Aditxt, Inc. (NASDAQ:ADTX) saw a large growth in short interest during the month of April. As of April 15th, there was short interest totalling 212,300 shares, a growth of 988.7% from the March 31st total of 19,500 shares. Based on an average trading volume of 361,100 shares, the short-interest ratio is currently 0.6 days. Approximately 10.8% of the company’s shares are sold short.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Aditxt stock. Armistice Capital LLC acquired a new stake in shares of Aditxt, Inc. (NASDAQ:ADTX) in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund acquired 28,000 shares of the company’s stock, valued at approximately $350,000. Armistice Capital LLC owned 11.67% of Aditxt as of its most recent SEC filing. Institutional investors and hedge funds own 15.54% of the company’s stock.

Aditxt Trading Down 5.5 %

Shares of ADTX opened at $2.39 on Friday. The stock has a fifty day moving average of $3.20 and a two-hundred day moving average of $4.52. Aditxt has a fifty-two week low of $2.14 and a fifty-two week high of $68.08.

About Aditxt

Aditxt, Inc, a biotech company, develops technologies focuses on improving the health of the immune system through immune mapping and reprogramming. The company develops AditxtScore that allows individuals to understand, manage, and monitor their immune profiles in order to be informed about attacks on or by their immune system; and Apoptotic DNA Immunotherapy, a nucleic acid-based technology that utilizes an approach that mimics the way the body naturally induces tolerance to its own tissues.